Lenient versus strict instructions after heart device surgery
Part of Infections clinical trials.
This trial compares two styles of “post-surgery instructions” after implantation of a new heart device lead. It may help determine which approach is better for patients’ recovery and safety after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having heart device surgery that includes implanting at least one new lead (the wires inside the heart/veins).
- Your surgery is not only a battery (“generator”) replacement for an existing device.
- Your device is not a subcutaneous (under-the-skin) defibrillator.
- Your pacemaker is not a leadless pacemaker (a pacemaker without wires).
- You are not getting a temporary “permanent” pacemaker setup.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how to manage and check implanted heart devices (pacemakers/defibrillators) during and around a planned procedure. It may help teams improve safety and decision-making during surgery or catheter procedures.
This study looks at how patients recover after getting a pacemaker put in or upgraded. It may help find better ways to support recovery and improve quality of life.
This trial tests a new device that measures heart function closely after heart surgery. It may help doctors give better care if you are in the heart intensive care unit after your operation.
This study tests whether using an arm sling for a short time after getting a heart device helps with recovery. It compares sling use to usual care to see which is better for comfort and healing.
This trial studies whether the ContraBand device can be safely placed in people with long-term, symptomatic heart failure and reduced heart pumping. It also looks at whether the approach is practical and tolerable, and gathers early safety information.
This study looks at whether implantable defibrillators can reduce dangerous heart rhythms in people with non-ischemic cardiomyopathy (heart weakness not caused by blocked heart arteries), a heart scar, and very low pumping strength despite best treatment. It compares different approaches to choosing which patients should receive these devices.
Hear when a new Post-Op Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.